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Background: Melanoma is a cancer of the skin and is increasing in incidence in the UK and Europe. 
Melanoma is a condition that is often curable if detected at an early stage, which makes accurate diag-
nosis vital. Reflectance confocal microscopy (RCM) is a tool used to image the skin. It gives high mag-
nification images of the skin, which may provide more accurate diagnosis of lesions that are equivocal 
on clinical examination and dermoscopy.
Objective: To determine the diagnostic accuracy of reflectance confocal microscopy (RCM), for mela-
noma diagnosis, as an add-on test to clinical examination and dermoscopy in the diagnosis of equivo-
cal pigmented skin lesions using histopathology as the reference standard.
Methods: A search was conducted of MEDLINE, EMBASE and six other electronic databases from 
inception to present. Forward citation searching and hand searching of reference lists were also con-
ducted. Diagnostic accuracy studies that assess RCM in the diagnosis of melanoma were included in 
the review. Two contributors conducted the search, data extraction and assessment of methodological 
quality using QUADAS-2. Statistical analysis was performed using hierarchical bivariate random ef-
fects meta-analysis.
Results: 951 titles and abstracts were screened. Five studies comprising 909 lesions were eligible for 
meta-analysis. Meta-analysis returned a per lesion sensitivity of 93% [95% CI 89-96] and a specificity 
of 76% [95% CI 68-83].
Conclusions: The utility of reflectance confocal microscopy (RCM) as an add-on test for the diagnosis 
of melanoma depends on the trade off between over-excising benign lesions and misdiagnosing mela-
noma as benign. This becomes important when considering lesions on surgically difficult or cosmeti-
cally important areas of the body.
ABSTRACT
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the 1990’s. The devices are now small and ergonomically able 
to image most areas of the skin. The diagnostic features are 
easy to learn and reproducible [13,16]. The devices them-
selves are quite, they are in limited use in clinical practice [17] 
and combined with the time to assess each lesion, may restrict 
the use to specialist clinics.
A comprehensive search found no systematic reviews or 
meta-analysis. Systematic reviews are important as they allow 
for a more transparent and objective appraisal of the evidence. 
Meta-analysis where appropriate can enhance the precision 
of the estimates of individual studies [18]. The objective for 
this review is to examine the diagnostic accuracy of RCM in 
the diagnosis of melanoma as an add-on test for lesions that 
are clinically and/or dermoscopically equivocal/suspicious 
for melanoma in cohort studies that have used a predefined 
threshold. This must be a pre-defined scoring system or system 
of diagnosis but there is no restriction on the system. Meta-
analysis will be conducted if there is sufficient consistency 
between studies in the way the thresholds are applied.
Methods
Search strategy
Electronic searches were conducted of Medline, Embase, 
CINAHL, the Cochrane Register of Diagnostic Test Accu-
racy Studies, DARE (Database of Abstracts of Reviews of 
Effects), Health Technology Assessment (HTA) database 
(The Cochrane Library), MEDION (The Medion data-
base) and NHS Economic Evaluation Database (NHSEED). 
The detailed search strategy for Medline (PubMed) used 
the following terms, CSLM, Laser microscope*, Confocal 
microscope*, Confocal scanning microscope*, Microscopy, 
confocal (MeSH), Melanoma (MeSH), Melanoma*, Hutchin-
son* freckle, Nevus, Nevi, Mole*, Skin cancer*, Cutane-
ous neoplasm*, Skin neoplasms (MeSH), Skin neoplasms, 
Nevus[MeSH], Melanocytes[MeSH], Skin tumour*, Skin 
tumor*, Skin lesion*, Melanocytic. The terms were adapted 
for the other databases as appropriate. The searches were per-
formed from database inception. The search was conducted 
by two independent reviewers.
Manual searches were conducted of the reference lists of 
the review articles and studies included in the final analysis. 
Forward citation searching was performed on all relevant 
retrieved articles via SCOPUS and Science Citation Index. 
The ‘related articles’ function of PubMed was used to look 
at the first 20 articles retrieved. No language restriction was 
applied to the electronic searches. The search was restricted to 
studies on humans. All the major journals were indexed. The 
searching authors felt that there was sufficient information 
provided in the articles and therefore correspondence with 
authors was not performed. The studies were included if they 
met the following criteria:
Introduction
Melanoma is a cancer of the skin which is increasing in 
frequency both in the UK and Europe1. Cancer research UK 
(CRUK) have calculated that in the 35 years from 1975-2010 
the age standardized incidence rate in the UK rose from 3.2 
per 100000 to 17.2 per 1000002. The biggest risk factor for 
developing melanoma is exposure to ultraviolet light [3].
Prognosis for melanoma is very much dependent on the 
stage of the disease when it is diagnosed so early accurate 
diagnosis of melanoma is crucial. The five-year survival for 
stage 1A melanoma is 97%. The five-year survival drops 
rapidly to 10-15% for stage 4 metastatic disease [4]. This 
rapid decline in survival with higher stage is because the only 
potentially curative treatment is surgical excision [5]. Adju-
vant therapy for non-metastatic melanoma has not yet been 
demonstrated to provide a survival benefit [6] and no therapy 
has proven to extend survival for metastatic melanoma [7,8].
The currently accepted best diagnostic method for mela-
noma is dermoscopy [9].
A recent meta-analysis of dermoscopy in the diagnosis of 
melanoma pooled the sensitivities and specificities and found a 
sensitivity of 91% and a specificity of 86% [10]. Most dermos-
copy research has been conducted in white skinned populations 
however there is some evidence of the ability of dermoscopy to 
work equally well in non-white populations [11].
Reflectance confocal microscopy (RCM) also known as 
confocal laser scanning microscopy (CLSM) of the skin was 
first described in the early 1990s [12]. This technology uses 
a near infrared laser to obtain images of the top layers of the 
skin. These images are magnified such that they are “quasi-
histological.” From the images, information can be obtained 
regarding cell structure and the architecture of the surround-
ing tissues. The images are analyzed and combinations of 
features are assessed to give a positive or negative diagnosis 
of melanoma. Several criteria have been developed to analyze 
images of RCM [13]. The test itself takes about ten minutes 
for imaging and evaluation of a skin lesion.
The goal of diagnosing melanoma is to correctly identify 
melanomas, while at the same time, excising as few benign 
lesions as possible. The most appropriate first line examina-
tion for this is dermoscopy, which has been shown to be a 
more accurate diagnostic tool than unaided eye examination 
[9]. Given the time needed to use RCM, it is most appropri-
ate as a secondary examination add test to dermoscopy for 
lesions where dermoscopy does not give a confident diagno-
sis. This role has been suggested previously [14,15].
There have been many narrative reviews on the use of 
RCM in the diagnosis of melanoma. These articles have 
focused mainly on describing the technology and discussing 
its potential role in melanoma diagnosis. RCM technology 
has advanced since the first instruments were introduced in 
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Assessment of methodological quality
Two authors independently assessed methodological quality 
of the studies using the QUADAS-2 tool [23]. Any disagree-
ments were resolved by discussion. The results of the quality 
assessment are presented with a textural methodological 
quality summary and graphical representation.
Results
Search
The search of the databases was conducted on February 8, 
2012. After screening for duplicates 951 studies were exam-
ined. A flow diagram of the search can be found in Figure 1.
After examining titles and abstracts the full text of 39 
articles were retrieved. There were five articles that met the 
inclusion criteria. These are shown in Table 1.
Excluded studies
There were five studies, which were derivation studies, 
or studies that did not validate on a new set of patients. 
There were 15 descriptive correlation studies, which only 
described which RCM features were associated with mela-
noma. There were four case reports or small case series, two 
narrative review articles, one editorial and one study looking 
at observer agreement of the RCM features associated with 
melanoma.
Methodological quality assessment
The exclusion criteria for studies in the review included two 
major methodological quality criteria. The studies could not 
be case control studies nor could they be studies that set a 
diagnostic threshold i.e.: studies that developed a scoring sys-
tem. Case control studies have been demonstrated to overes-
timate diagnostic accuracy when compared to cohort studies 
that use an appropriate spectrum [24]. Studies that derive/set 
a threshold use multivariable analysis to derive a score. These 
scores are derived on a certain population. It is very often the 
case that these scoring systems perform worse when they are 
validated in another population, however similar [25].
This resulted in a low risk of bias regarding the appli-
cability of the included patients and the appropriateness of 
the index test. In this study, the reporting of patient selection 
was generally poor however all domains were graded as low 
risk of bias. The methodological quality assessment is shown 
graphically in Table 2.
Findings
Five studies were identified comprising 909 lesions. The 
average prevalence of melanoma was 36.2% with a range 
from 29-39. Three studies used the RCM diagnostic scor-
Type of study
Cohort studies of diagnostic test accuracy with a predefined 
threshold that was established on separate data are eligible 
for inclusion.
Target condition
Melanoma of the skin.
Study population
Patients presenting with lesions suspicious for melanoma that 
were equivocal to clinical and dermoscopic diagnosis. No 
restriction was placed upon participant characteristics such 
as age, sex, ethnicity etc.
Index test
Reflectance confocal microscopy. There was no restriction on 
the type of algorithm or diagnostic process.
Reference standard
Histopathology of the excised skin lesion or long-term clini-
cal follow-up.
Data extraction and management
Per lesion data was extracted onto a study specific data 
extraction sheet by two authors independently. The following 
data was collected: the details of the study population, details 
of the reference standard and index test, blinding of the refer-
ence standard and the index test. Prevalence of melanoma, 
information to complete the 2 x 2 table.
Statistical analysis and data synthesis
Data were extracted by two reviewers independently. Hier-
archical bivariate random-effects meta-analysis [19] was 
used to perform the statistical meta-analysis as this has been 
demonstrated to be the most robust method [19].
If there appeared to be no or minimal threshold differ-
ences between the studies clinically or on the receiver opera-
tor characteristic (ROC) plot then a summary statistic in the 
form of sensitivity and specificity was planned [20]. If there 
were, clinically and visually, the appearance of a threshold 
effect then the summary ROC curve was planned as the most 
appropriate summary measure [20].
If a study presented several sensitivity and specificity 
estimates on a receiver operator characteristic curve (ROC) 
then the point estimate used for meta-analysis was the point 
chosen by the author of the article.
The results are presented graphically using RevMan5 
[21]. The studies were combined in a statistical meta-analysis 
using the METANDI function in STATA [22].
Subgroup analyses was intended for investigation of 
operator experience and algorithm method however there 
was an insufficient number of studies.
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Per lesion sensitivity and specificity are shown on a forest 
plot in Figure 2. There appears to be minimal heterogeneity 
per lesion in sensitivity across the studies, with more hetero-
geneity in the specificity.
Based upon this a hierarchical summary receiver opera-
tor characteristic (HSROC) curve was obtained using the 
bivariate method. The diagnostic accuracy results are quite 
similar in all studies and there is no evidence of a threshold 
effect or apparent threshold effect. The plot of this is shown 
in Figure 3. From meta-analysis the operating point had a 
sensitivity of 93.3% [95% CI 88.5-96.2, range 91% to 97%] 
and a specificity of 75.9% [95% CI 67.9-82.5, range 68% 
to 86%].
ing system developed by Pellacani 200526 (Curchin 2011, 
Guitera 2009, Pellacani 2007), two used a scoring system 
for lentigo maligna developed by Guitera 201027 (Guitera 
2010, Curchin 2011) and one did not use a specific diagnostic 
algorithm but made RCM diagnoses based upon pre-specified 
melanoma associated features (Langley 2007). The operators 
were self identified as experienced in four out of the five 
studies and inexperienced in one (Curchin 2011). There were 
no explicit differences in the spectrum of disease of patients 
being examined with RCM. All studies examined equivocal 
skin lesions. One study was exclusively limited to equivo-
cal skin lesions on the face (Guitera 2010) and two studies 
excluded lesions on the face (Pellacani 2007 Guitera 2009).
Figure 1. PRISMA flow diagram. [Copyright: ©2013 Stevenson et al.]
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patient outcomes compared to the existing diagnostic path-
way. It is not enough just to measure the sensitivity and 
specificity [28].
Duff et al. [29] and Rampen et al. [30] followed patients 
after melanoma screening, searching for missed melanomas. 
Duff found no missed melanomas from 1961 patients and 
Rampen found seven invasive melanomas and two lentigo 
maligna (a type of melanoma in situ) from 9968 patients 
seen in the clinic. This data suggests that, in real clinical 
contexts using current diagnostic technology, few melanomas 
are missed.
The purpose of this review was to evaluate RCM as an 
add-on test to existing diagnostic pathways, not to evaluate 
it as a replacement test. It has been suggested that RCM is 
more sensitive than dermoscopy [13]. If all lesions that were 
suspicious to the unaided eye examination were examined 
Given the low number of studies included in the review, 
statistical subgroup analysis and covariate hierarchical mod-
eling for investigation of heterogeneity were not performed 
due to low statistical power.
Discussion
When examining the use of a new diagnostic test it is 
important to consider whether its introduction will improve 
 TABLE 1. Characteristics of included studies
First author 
and year
Country 
of study
Algorithm
Patient 
Characteristics
Number 
of lesions
Reference 
standard
Number of 
patients
Melanoma 
frequency
Curchin 
201117
Australia Pellacani 2005, 
Guitera 2010
Data not available 35 Histology Not 
available
37%
Guitera 
200915
Italy and 
Australia
Pellacani 2005 Median age and 
IQR 47(36-60).
F:M 149:177
326 Histology 326 37%
Guitera 
201027
Australia 
Italy and 
USA
Guitera 2010 Data not available 73 Histology/
long term 
follow up
Not 
available
37%
Pellacani 
200714
Italy and 
Australia
Pellacani 2005 Median age 
and IQR 
47.7(35.9-60.4).
F:M 158:174
351 Histology 332 37%
Langley 
200733
Canada No named 
diagnostic 
algorithm
Average age: 44 
range: 16-84
125 Histology 125 29%
[Copyright: ©2013 Stevenson et al.]
  TABLE 2. QUADAS-2 Risk of bias assessment.
Study
Risk Of Bias Applicability Concerns
Patient 
Selection
Index Test
Reference 
Standard
Flow And 
Timing
Patient 
Selection
Index Test
Reference 
Standard
Curchin 2011       
Guitera 2009       
Guitera 2010   ?      
Pellacani 2007   ?      
Langley 2007       
 Low Risk  High Risk ? Unclear Risk 
[Copyright: ©2013 Stevenson et al.]
Figure 2. Forest plot of the studies. [Copyright: ©2013 Stevenson 
et al.]
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If the role of RCM is as an add-on test, all lesions that 
are examined with RCM have already been declared as posi-
tive by the existing pathway. Using RCM in this way will not 
increase the detection rate of the few melanomas that are cur-
rently being misdiagnosed as benign as they will have already 
left the diagnostic pathway. It is possible that the availability 
of RCM may change clinician confidence and diagnostic 
threshold. Instead of the clinical/dermoscopic diagnosis being 
the final step before a management decision is made, RCM 
would exist as an add-on test. The individual clinician might 
change his or her threshold to be more sensitive and less 
specific in order to capture more disease. This has not been 
addressed in these studies however it may change the sensitiv-
ity and specificity of RCM in actual clinical practice. Another 
area where it may be helpful is if the clinician is suspicious of 
a lesion, especially featureless pink lesions, and are consider-
ing monitoring it the clinician may well use RCM and find 
that it is positive and proceed with excision. The risk here is 
if it is RCM negative and the clinician does not follow it up 
with some monitoring procedure they may miss a melanoma.
To gauge the trade off between the reduction in unneces-
sary biopsies and the missed melanoma diagnoses the sensitiv-
ity and specificity can be applied to an estimated prevalence 
of melanoma in the spectrum of patients that would be 
selected for RCM examination.
The average prevalence of melanoma in the studies 
included in the review was 36%. In a 2002 systematic review 
of dermoscopy the mean frequency of melanoma was 28%. 
Previous research has suggested a malignant to benign ration 
of 1:4 with the expert use of dermoscopy [32]. This translates 
to a frequency melanoma in dermoscopy positive lesions of 
20%. If we assume that in real clinical practice the clearly 
positive melanomas would not be examined with RCM, we 
can gauge an estimated frequency of disease in dermoscopy 
positive lesions would be slightly lower.
Figure  4 demonstrates a flow diagram of the impact of 
RCM in its proposed role as an add on test to dermoscopy 
using a sensitivity of 93% and a specificity of 75% as calcu-
lated in the meta-analysis and a melanoma frequency of 20%. 
For 1000 dermoscopy positive lesions, there would be 200 
melanomas. RCM would correctly identify 186 of these and 
miss [14]. There would be 192 benign lesions excised and 608 
benign lesions not excised.
The only benefit of RCM in this pathway is to increase 
the specificity of diagnosis and reduce the number of benign 
lesions excised. The value of reflectance confocal microscopy 
as an add-on test in the diagnosis of melanoma depends on 
the trade off between the harms associated with excising 
benign lesions and the harms associated with misdiagnosing 
a melanoma as benign. If RCM is to be used in clinical prac-
tice a decision has to be made weighing up the consequences 
with dermoscopy and RCM then this is no doubt the case. 
This, however, is not helpful for clinical practice. It takes 
seconds to examine a lesion with dermoscopy and minutes 
to examine a lesion with RCM. RCM is not going to take on 
the role of dermoscopy. Therefore it is not useful to compare 
RCM to the sensitivity and specificity of dermoscopy. Instead, 
it should be considered as an add-on test to the best current 
clinical diagnostic tool, which in this case is dermoscopy.
If RCM were to be used as an add-on test in clinical 
practice, the population examined with RCM would be the 
narrow pre-selected group of those in whom dermoscopy was 
not clearly positive or not clearly negative. The population 
of lesions being examined with RCM in these studies was 
not clear and reproducible. The terms “clinically suspicious” 
and “equivocal” do not give the reader sufficient informa-
tion. It is not certain that the lesions examined by RCM in 
the studies were the same that would be examined by RCM 
in clinical practice. If the lesions examined in these studies 
included those that were clearly melanoma then the spectrum 
of disease would be different to that in clinical use and this 
could bias the result leading to an over estimate of sensitivity 
and specificity.
These factors combined with the concept that diagnostic 
accuracy determined from laboratory condition studies may 
be different from the diagnostic accuracy in the real life clini-
cal setting [31], mean that the external validity of these results 
has to be taken cautiously.
Figure 3. Hierarchical summary receiver operator characteristic 
curve. [Copyright: ©2013 Stevenson et al.]
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in the images obtained. A study looking at the agreement 
between observers in identifying these features found high 
overall levels of reproducibility [16].
Weaknesses
A weakness of this review is that the current studies may not 
have focused on the pertinent patient populations to test the 
ability of RCM as an add-on test to dermoscopy. It is noted 
that in three of the five studies included in this review the 
main operators using RCM were Giovanni Pellacani and 
of missing a melanoma and the harms averted by avoiding 
performing un-necessary excisions.
Excision of skin lesions on most areas of the body is often 
a quick and easy process that does not carry a great risk of 
morbidity. The situations where this is not the case are when 
lesions are on cosmetically sensitive areas of the body such 
as the face, head and neck or where skin surgery becomes 
complex, involving the use of skin grafts or flaps. It is these 
lesions where the reduction in benign lesion excision would 
have the most impact.
The algorithms that have been developed for use in mela-
noma diagnosis are based upon several features observed 
Figure 4. Proposed role of RCM in diagnostic pathway: Hypothetical example based on 1000 lesions positive with 
dermoscopy. [Copyright: ©2013 Stevenson et al.]
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13.  Gerger A, Hofmann-Wellenhof R, Samonigg H, Smolle J. In vivo 
confocal laser scanning microscopy in the diagnosis of melano-
cytic skin tumours. Br J Dermatol. 2009;160(3):475-81.
14.  Pellacani G, Guitera P, Longo C, et al. The impact of in vivo 
reflectance confocal microscopy for the diagnostic accuracy of 
melanoma and equivocal melanocytic lesions. J Invest Dermatol. 
2007;127(12):2759-65.
15.  Guitera P, Pellacani G, Longo C, et al. In vivo reflectance confocal 
microscopy enhances secondary evaluation of melanocytic lesions. 
J Invest Dermatol. 2009;129(1):131-8.
16.  Pellacani G, Vinceti M, Bassoli S, et al. Reflectance confocal mi-
croscopy and features of melanocytic lesions: An internet-based 
study of the reproducibility of terminology. Arch Dermatol. 
2009;145(10):1137-43.
17.  Curchin CES, Wurm EMT, Lambie DLJ, et al. First experiences 
using reflectance confocal microscopy on equivocal skin lesions 
in Queensland. Australas J Dermatol. 2011;52(2):89-97.
18.  Egger M, Smith GD, O’Rourke K. Rationale, potentials, and 
promise of systematic reviews. In: Egger M, Smith GD, Altman 
DG (eds.). Systematic Reviews In Health Care: Meta-analysis In 
Context. 2nd ed. London: BMJ Books, 2001.
19.  Harbord RM, Whiting P, Sterne JA, et al. An empirical com-
parison of methods for meta-analysis of diagnostic accuracy 
showed hierarchical models are necessary. J Clin Epidemiol. 
2008;61(11):1095-103.
20.  Macaskill P Gatsonis C, Deeks JJ, Harbord RM, Takwoingi 
Y. Chapter 10: Analysing and Presenting Results. In: Deeks JJ 
Bossuyt PM, Gatsonis C (eds.). Cochrane Handbook for Sys-
tematic Reviews of Diagnostic Test Accuracy Version 1.0. The 
Cochrane Collaboration, 2010.
21.  Copenhagen: The Nordic Cochrane Centre TCC. Review Man-
ager (RevMan). 5.1 ed, 2011.
22.  Harbord R. METANDI: Stata module to perform meta-analysis 
of diagnostic accuracy. Statistical Software Components S456932, 
Boston College Department of Economics, 2008.
23.  Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a 
revised tool for the quality assessment of diagnostic accuracy 
studies. Ann Int Med. 2011;155(8):529-36.
24.  Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence 
of design-related bias in studies of diagnostic tests. JAMA. 
1999;282(11):1061-6.
25.  Buntinx F, Aertgeerts B, Aerts M, et al. Chapter 8. Multivariable 
analysis in diagnostic accuracy studies: what are the possibilities? 
In: Knottnerus JA, Buntinx F (eds.). The Evidence Base of Clinical 
Diagnosis: Theory and Methods of Diagnostic Research. 2nd ed. 
Oxford: Wiley-Blackwell, 2009.
26.  Pellacani G, Cesinaro AM, Seidenari S. Reflectance-mode confocal 
microscopy of pigmented skin lesions—improvement in melanoma 
diagnostic specificity. J Am Acad Dermatol. 2005;53(6):979-85.
27.  Guitera P, Pellacani G, Crotty KA, et al. The impact of in vivo 
reflectance confocal microscopy on the diagnostic accuracy of 
lentigo maligna and equivocal pigmented and nonpigmented 
macules of the face. J Invest Dermatol. 2010;130(8):2080-91.
28.  Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and 
specificity sufficient to evaluate a diagnostic test, and when do 
we need randomized trials? Ann Int Med. 2006;144(11):850-5.
29.  Duff CG, Melsom D, Rigby HS, Kenealy JM, Townsend PL. A 6 
year prospective analysis of the diagnosis of malignant melanoma 
in a pigmented-lesion clinic: even the experts miss malignant 
melanomas, but not often. Br J Plas Surg. 2001;54(4):317-21.
Pascale Guitera. In addition the small number of studies and 
poor reporting in the primary studies limited the scope of 
the review.
Summary
Reflectance confocal microscopy may contribute to the diag-
nosis of melanoma as an add-on test in the diagnostic path-
way to reduce over-diagnosis following dermoscopy. Reduc-
tion in the excision rate of benign lesions that look suspicious 
on clinical examination may be important particularly where 
treatment by removal is potentially difficult or harmful. As no 
diagnostic test is 100% accurate, each clinician and patient 
will have to decide if the trade off between missing a small 
number of melanomas is worth the reduction in excision of 
benign lesions.
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